Tenderwize
Zurück zur Suche

Open House Discount Agreements for the Active Substance Posaconazole, ATC J02AC04

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Mar 31, 2027 · 217 days left·Open·Supplies
Structured notice only
Originaltitel der Bekanntmachung

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Posaconazol, ATC J02AC04

65/100

Opportunity Score

PromisingLow complexity
SuppliesOpen
Warum diese Bewertung?

Chance

65 / 100

Komplexität

30 / 100

Risikofaktoren

The buyer can replace the open house agreement with exclusive contracts at any time, leading to automatic termination o...

No estimated or guaranteed contract value is provided; actual revenue depends on prescription volume and discount rates.

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Überblick

Strong opportunity

Wichtige Fakten

  • Supplies contract
  • 1 lot
  • Duration until May 2027
  • Supply of pharmaceutical products containing the active substance Posaconazole (ATC J02AC04).
  • Conclusion of non-exclusive discount agreements with the buyer.
Vollständige Zusammenfassung anzeigen

Open House non-exclusive discount agreements for the active substance Posaconazole (ATC J02AC04) offered by AOK Rheinland-Pfalz/Saarland. This is not a standard EU public procurement but a voluntary transparency publication. The contract runs from June 2025 to May 2027, with rolling enrollment on the first of each month. No estimated value is provided. Selection is based solely on the eligibility of the pharmaceutical product (authorized and marketable in Germany). No award criteria or competitive evaluation apply.

Risiken

The buyer can replace the open house agreement with exclusive contracts at any time, leading to automatic termination o...

No estimated or guaranteed contract value is provided; actual revenue depends on prescription volume and discount rates.

Analyse kann unvollständig sein

Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.

Wichtige Anforderungen

Technical

  • Medicines must be authorized and marketable in Germany.
  • Proof of marketability via Lauer-Taxe listing or AMIce database extract.

Administrative

  • Submission of signed contract documents by specific deadlines for each enrollment date.

Anforderungen können unvollständig sein.

Auftraggeber

Lose (1)

LOT-0001

Open House Discount Agreements for the Active Substance Posaconazole, ATC J02AC04

Non-exclusive discount agreements for Posaconazole products. All interested pharmaceutical companies can join under uniform terms. The contract period is a maximum of 24 months, starting 01.06.2025. The buyer reserves the right to replace these open house agreements with exclusive contracts via regular tenders.

SuppliesEU fundedElectronic submission

Ort

Eisenberg, Germany

Dauer

May 2025 - May 2027

Kategorie

Pharmaceutical products

Frist

Deadline May 31, 2027

Vergabedetails

Veröffentlichungsdatum
10 Apr 2025
Sprachen
German

Referenzmetadaten

Rechtsgrundlage
32014L0024

Referenz-IDs

Ausschreibungs-ID
235079-2025

Dokumente (1)

Ähnliche Ausschreibungen